Paragon 28® launches sterile kit configuration to streamline delivery of first-of-its-kind hammertoe and plantar plate repair solution – TenoTac® Soft Tissue Fixation System

ENGELWOOD, Colo., Nov. 14, 2019 /PRNewswire/ — Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

Paragon 28® launched the TenoTac Soft Tissue Fixation System in January 2019 providing surgeons the first and only dedicated system to address tendon transfers of the forefoot.  In contrast to traditional methods for flexor tendon transfers, TenoTac™ facilitates correction without releasing tissue attachments distally by balancing plantar and dorsal tension.  Plantar and dorsal tissue distal to the TenoTac® are locked in and balanced, while tissue proximal to the tack is bolstered and stabilized.  The system requires a small incision plantarly which avoids the weight bearing surface and small incision dorsally to facilitate implantation, resulting in less swelling, pain, and scarring when compared to traditional approaches.

The TenoTac™ Soft Tissue Fixation System uses a titanium threaded implant and a simple insertion method to gain optimal fixation of soft tissue to bone. The phalanx is prepped with the provided instrumentation and the plantar tack is inserted into the bone tunnel capturing the plantar tendons. Once inserted, temporary fixation and correction are achieved by holding manual tension over the tendon and bone. While maintaining this tension, the dorsal sleeve of the implant is mated to the plantar tack by threading the two components together capturing the tendon plantarly completing the correction.

TenoTac™ Sterile and Non-sterile Configurations

The launch of the sterile kit configuration eliminates the need for pre-operative sterilization and has simplified the back table for surgical technicians and surgeons.  All components of the system are now delivered in one neatly organized kit which a rep can walk into the OR and provide at a moments notice.  The sterile launch is expected to greatly expand accessibility to this elegant solution allowing clinicians and health care networks the most efficient and safe access to the TenoTac™ System. 

For more information, please visit http://www.paragon28.com/products/tenotac-soft-tissue-fixation-system/

Jim Edson

SOURCE Paragon 28, Inc.

Print Friendly, PDF & Email

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Back to top button